Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

26 août 2025 05h00 HE | Source: Er-Kim Pharmaceuticals

Er-Kim Announces Exclusive Agreement with CNX Therapeutics to Distribute Oncology Products Across CEE and Turkey

Er-Kim signs distribution agreement with CNX Therapeutics to distribute its portfolio of oncology medications across CEE and Turkey.
30 juin 2025 08h00 HE | Source: Er-Kim Pharmaceuticals

Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions

Er-Kim has partnered with Immunocore to bring KIMMTRAK (tebentafusp) to patients in Turkey, MENA, Caucasus, and CIS regions
10 déc. 2024 07h00 HE | Source: Er-Kim

Er-Kim Extends Exclusive Distribution Agreement with Ascendis Pharma A/S to Expand Commercialization of Its Endocrinology Portfolio to Eurasian Markets

Er-Kim broadens drug distribution for novel rare endocrinology disease therapies in CEE and Eurasian markets
15 oct. 2024 07h00 HE | Source: Er-Kim

Er-Kim CEO Cem Zorlular Recognized as a Patient Champion on the 2024 PharmaVoice 100

Cem Zorlular, CEO of Er-Kim recognized as a patient champion in this year's PharmaVoice100